| View |
|
DRP-3612
|
Ibuprofen + Paracetamol
|
Ibumol
|
200mg/ 325mg
|
Capsule
|
Analgesic/ Antipyretic
|
Interphil Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
27 December 2021
|
26 July 2027
|
| View |
|
DRP-3880
|
Salbutamol (As Sulfate)
|
Asmacaire
|
2mg/5mL
|
Syrup
|
Selective beta 2-adrenoreceptor agonist
|
E.L. Laboratories, Inc
|
Philippines
|
Automatic Renewal
|
31 January 2022
|
18 April 2027
|
| View |
|
DRP-452-01
|
Ambroxol Hydrochloride
|
Mucosolve
|
30mg
|
Tablet
|
Mucolytic
|
Lumar Pharmaceutical Laboratory
|
Philippines
|
Automatic Renewal
|
29 March 2022
|
23 May 2027
|
| View |
DR-XY48137_PI_01.pdf
|
DR-XY48137
|
Abrocitinib
|
Cibinqo
|
100 mg
|
Film-coated Tablet
|
-
|
Pfizer Manufacturing Deutschland GmbH
|
Germany
|
Monitored Release
|
27 June 2022
|
27 June 2027
|
| View |
DR-XY48139_PI_01.pdf
|
DR-XY48139
|
Ciprofloxacin
|
Ciclodin IV
|
2mg/mL (400mg/200mL)
|
Solution for IV Injection
|
-
|
CJ Healthcare Corporation
|
Korea
|
Initial
|
28 June 2022
|
28 June 2027
|
| View |
|
DRP-12191
|
Loratadine
|
Loratamed
|
10 mg
|
Chewable Tablet
|
Antihistamine
|
Ratnamani Healthcare Pvt. Ltd.
|
India
|
Initial (OTC)
|
28 June 2022
|
28 June 2027
|
| View |
|
DRP-12190
|
Loperamide Hydrochloride
|
Loperamed
|
2 mg
|
Capsule
|
Antidiarrheal
|
Ratnamani Healthcare Pvt. Ltd.
|
India
|
Initial (OTC)
|
28 June 2022
|
28 June 2027
|
| View |
DRP-4391-08_PI_01.pdf
|
DRP-4391-08
|
Azithromycin (as dihydrate)
|
Azithrospeed
|
500mg
|
Film Coated Tablet
|
Antibacterials (Macrolides)
|
Interphil Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
28 February 2023
|
29 April 2028
|
| View |
|
DRP-12185
|
Losartan Potassium + Hydrochlorothiazide
|
Losarx Plus
|
100 mg/25 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor blocker (ARB)/ Diuretic
|
Fredun Pharmaceuticals Limited
|
India
|
Initial
|
27 June 2022
|
27 June 2027
|
| View |
|
DRP-12188
|
Losartan Potassium + Hydrochlorothiazide
|
Losarx Plus
|
100 mg/12.5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor blocker (ARB)/ Diuretic
|
Fredun Pharmaceuticals Limited
|
India
|
Initial
|
27 June 2022
|
27 June 2027
|
| View |
|
BRP-111
|
Rituximab
|
Rixathon
|
100 mg/10 mL (10mg/mL)
|
Concentrate For Solution For Infusion (IV)
|
-
|
Lek Pharmaceuticals D.D
|
Slovenia
|
Initial
|
27 June 2022
|
27 June 2027
|
| View |
|
BRP-110
|
Rituximab
|
Rixathon
|
500 mg/50 mL (10mg/mL)
|
Concentrate For Solution For Infusion (IV)
|
-
|
Lek Pharmaceuticals D.D
|
Slovenia
|
Initial
|
27 June 2022
|
27 June 2027
|
| View |
|
DR-XY48133
|
Topiramate
|
Trokendi XR
|
25 mg
|
Extended Release Capsule
|
-
|
Orient Pharma Co., Ltd.
|
Taiwan
|
Monitored Release
|
23 June 2022
|
23 June 2025
|
| View |
|
DR-XY48129
|
Topiramate
|
Trokendi XR
|
100 mg
|
Extended Release Capsule
|
Antiepileptic
|
Orient Pharma Co., Ltd.
|
Taiwan
|
Monitored Release
|
22 June 2022
|
22 June 2025
|
| View |
|
DR-XY48123
|
Topiramate
|
Trokendi XR
|
200 mg
|
Extended Release Capsule
|
-
|
Orient Pharma Co., Ltd.
|
Taiwan
|
Monitored Release
|
21 June 2022
|
21 June 2025
|
| View |
|
DR-XY48134
|
Topiramate
|
Trokendi XR
|
25 mg
|
Extended Release Capsule
|
Antiepileptic
|
Orient Pharma Co., Ltd.
|
Taiwan
|
Monitored Release
|
23 June 2022
|
23 June 2025
|
| View |
|
DR-XY48130
|
Topiramate
|
Trokendi XR
|
100 mg
|
Extended Release Capsule
|
-
|
Orient Pharma Co., Ltd.
|
Taiwan
|
Monitored Release
|
22 June 2022
|
22 June 2025
|
| View |
|
DR-XY48126
|
Topiramate
|
Trokendi XR
|
200 mg
|
Extended Release Capsule
|
Antiepileptic
|
Orient Pharma Co., Ltd.
|
Taiwan
|
Monitored Release
|
21 June 2022
|
21 June 2025
|
| View |
|
DRP-5382-03
|
Ampicillin(as sodium)+Sulbactam(as sodium)
|
Unbranded
|
1000/500mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Combination of penicillin and beta-lactamase inhibitor)
|
Shin Poong Pharmaceutical Co., Ltd
|
Korea
|
Renewal
|
17 April 2024
|
10 July 2029
|
| View |
|
DRP-12156
|
Paracetamol +Phenylephrine HCl + Chlorphenamine Maleate
|
Fluaid
|
500 mg/10 mg/2 mg
|
Film Coated Tablet
|
Analgesic/ Antipyretic/ Nasal Decongestant/ Antihistamine
|
Diamond Laboratories, Inc.
|
Philippines
|
Initial (OTC)
|
22 June 2022
|
22 June 2027
|